|
|
Previous Article | Table of Contents | Next Article 
Phenotypic and functional analysis of T-cell precursors in the human fetal
liver and thymus: CD7 expression in the early stages of T- and myeloid-cell
development
A Barcena, MO Muench, AH Galy, J Cupp, MG Roncarolo, JH Phillips and H Spits
Human Immunology Department, DNAX Research Institute, Palo Alto, CA
94304-1104.
It has been proposed that the CD7 molecule is the first antigen expressed
on the membrane of cells committed to the T-cell lineage during human fetal
T-cell ontogeny. To further identify the pre-T cell subpopulation that
migrates to the thymus early in ontogeny, we analyzed the phenotypic and
functional characteristics of the fetal liver populations separated on the
basis of CD7 expression. Three populations expressing different levels of
CD7 were observed: CD7bright, CD7dull, and CD7-. A CD7bright population
depleted of mature T, B, and myeloid cells (lineage negative, lin-) and
mostly composed of CD56+ CD34- natural killer cells did not mature into T
cells in a fetal thymic organ culture (FTOC) assay and was devoid of
myeloid progenitors in a clonal colony-forming cell assay. In contrast, the
CD7-/dull CD34+ lin- populations were capable of differentiating into
phenotypically mature T cells after injection into FTOC and contained early
myeloid progenitors. Here we phenotypically compared the fetal liver CD7
populations with the most immature fetal thymic subset that differentiated
in the FTOC assay, namely the triple negative (TN, CD3- CD4-CD8-)
thymocytes. Fetal TN lin- expressed high levels of CD34 marker and were
further subdivided by their expression of CD1 antigen, because CD1- TN
thymocytes express higher levels of CD34 antigen compared with CD1+ TN
cells. CD1- lin -TN thymocytes are characterized by expressing high levels
of CD2, CD7, and CD34 markers and dull levels of CD5, CD10, and CD28
molecules. We could not find fetal liver pre-T cells with a phenotype
equivalent to that of TN thymocytes. Our data show that CD7 does not
necessarily identify T-cell precursors during fetal T-cell development and
strongly support the hypothesis that the acquisition of early T-cell
markers as CD2, CD28, and CD5 molecules on the cell surface of T-cell
progenitors takes place intrathymically.
Volume 82,
Issue 11,
pp. 3401-3414,
12/01/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Q.-L. Hao, A. A. George, J. Zhu, L. Barsky, E. Zielinska, X. Wang, M. Price, S. Ge, and G. M. Crooks
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors
Blood,
February 1, 2008;
111(3):
1318 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kotsianidis, J. D. Silk, E. Spanoudakis, S. Patterson, A. Almeida, R. R. Schmidt, C. Tsatalas, G. Bourikas, V. Cerundolo, I. A. G. Roberts, et al.
Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells
Blood,
April 15, 2006;
107(8):
3138 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bremer, B. t. Cate, D. F. Samplonius, L. F. M. H. de Leij, and W. Helfrich
CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia
Blood,
April 1, 2006;
107(7):
2863 - 2870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bremer, D. F. Samplonius, M. Peipp, L. van Genne, B.-J. Kroesen, G. H. Fey, M. Gramatzki, L. F.M.H. de Leij, and W. Helfrich
Target Cell-Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7
Cancer Res.,
April 15, 2005;
65(8):
3380 - 3388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kosugi, Y. Ebihara, T. Nakahata, H. Saisho, S. Asano, and A. Tojo
CD34+CD7+ Leukemic Progenitor Cells May Be Involved in Maintenance and Clonal Evolution of Chronic Myeloid Leukemia
Clin. Cancer Res.,
January 15, 2005;
11(2):
505 - 511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Hao, J. Zhu, M. A. Price, K. J. Payne, L. W. Barsky, and G. M. Crooks
Identification of a novel, human multilymphoid progenitor in cord blood
Blood,
June 15, 2001;
97(12):
3683 - 3690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Heinly, G. D. Sempowski, D. M. Lee, D. D. Patel, P. M. McDermott, R. M. Scearce, C. B. Thompson, and B. F. Haynes
Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice
Int. Immunol.,
February 1, 2001;
13(2):
157 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Canque, S. Camus, A. Dalloul, E. Kahn, M. Yagello, C. Dezutter-Dambuyant, D. Schmitt, C. Schmitt, and J. C. Gluckman
Characterization of dendritic cell differentiation pathways from cord blood CD34+CD7+CD45RA+ hematopoietic progenitor cells
Blood,
December 1, 2000;
96(12):
3748 - 3756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Storms, M. A. Goodell, A. Fisher, R. C. Mulligan, and C. Smith
Hoechst dye efflux reveals a novel CD7+CD34- lymphoid progenitor in human umbilical cord blood
Blood,
September 15, 2000;
96(6):
2125 - 2133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. A. Weekx, H. W. Snoeck, F. Offner, M. De Smedt, D. R. Van Bockstaele, G. Nijs, M. Lenjou, A. Moulijn, I. Rodrigus, Z. N. Berneman, et al.
Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-alpha
Blood,
May 1, 2000;
95(9):
2806 - 2812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Jaleco, A. P.A. Stegmann, M. H.M. Heemskerk, F. Couwenberg, A. Q. Bakker, K. Weijer, and H. Spits
Genetic Modification of Human B-Cell Development: B-Cell Development Is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3
Blood,
October 15, 1999;
94(8):
2637 - 2646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Sempowski, D. M. Lee, R. M. Scearce, D. D. Patel, and B. F. Haynes
Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes
J. Exp. Med.,
March 15, 1999;
189(6):
1011 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takahashi, I. Miura, K. Saitoh, and A. B. Miura
Lineage Involvement of Stem Cells Bearing the Philadelphia Chromosome in Chronic Myeloid Leukemia in the Chronic Phase as Shown by a Combination of Fluorescence-Activated Cell Sorting and Fluorescence In Situ Hybridization
Blood,
December 15, 1998;
92(12):
4758 - 4763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Dworzak, G. Fritsch, G. Froschl, D. Printz, and H. Gadner
Four-Color Flow Cytometric Investigation of Terminal Deoxynucleotidyl Transferase-Positive Lymphoid Precursors in Pediatric Bone Marrow: CD79a Expression Precedes CD19 in Early B-Cell Ontogeny
Blood,
November 1, 1998;
92(9):
3203 - 3209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Saitoh, I. Miura, N. Takahashi, and A. B. Miura
Fluorescence In Situ Hybridization of Progenitor Cells Obtained by Fluorescence-Activated Cell Sorting for the Detection of Cells Affected by Chromosome Abnormality Trisomy 8 in Patients With Myelodysplastic Syndromes
Blood,
October 15, 1998;
92(8):
2886 - 2892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Lee, H. F. Staats, J. S. Sundy, D. D. Patel, G. D. Sempowski, R. M. Scearce, D. M. Jones, and B. F. Haynes
Immunologic Characterization of CD7-Deficient Mice
J. Immunol.,
June 15, 1998;
160(12):
5749 - 5756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Muench, M. G. Roncarolo, and R. Namikawa
Phenotypic and Functional Evidence for the Expression of CD4 by Hematopoietic Stem Cells Isolated From Human Fetal Liver
Blood,
February 15, 1997;
89(4):
1364 - 1375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Knutsen, S. Roodman, M. Ruiz, K. Mueller, and J. Bouhasin
Development of a method of thymocyte differentiation of bone marrow- enriched CD34+CD38- cells in postnatal allogeneic cultured thymic epithelia to evaluate immunodeficiency disorders
Stem Cells,
November 1, 1996;
14(6):
702 - 713.
[Abstract]
|
 |
|
|
|